Cancer therapy has been rapidly advancing toward molecular characterization, however, screening technology such as mammograms can be painful and generally rely on anatomical differences that have several limitations. These include the lack of molecular information to identify aggressive tumors versus those that pose no mortality risk and the lack of contrast in dense breast tissue that carries increased risk, particularly